Pyrroloquinoline quinone: a potential neuroprotective compound for neurodegenerative diseases targeting metabolism by Alessio Canovai, Pete A. Williams

Get full text

Glycolysis and glucose metabolism as a target for bioenergetic and neuronal protection in glaucoma by Pete A Williams, Robert J Casson

Get full text

The prognostic implication of latitude in uveal melanoma: a nationwide observational cohort study of all patients born in Sweden between 1947 and 1989 by Gustav Stålhammar, Pete A. Williams, Tomas Landelius

Get full text

The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature by Anna Hagström, Ruba Kal Omar, Pete A. Williams, Gustav Stålhammar

Get full text

Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma by Anne Rombaut, Rune Brautaset, Pete A. Williams, James R. Tribble

Get full text

Glial metabolic alterations during glaucoma pathogenesis by Anne Rombaut, Rune Brautaset, Pete A. Williams, James R. Tribble

Get full text

Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume by Amin Otmani, Gauti Jóhannesson, Rune Brautaset, James R. Tribble, Pete A. Williams

Get full text

Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma by Gloria Cimaglia, James R. Tribble, Marcela Votruba, Pete A. Williams, James E. Morgan

Get full text

Neuroprotection in Glaucoma: NAD⁺/NADH Redox State as a Potential Biomarker and Therapeutic Target by Bledi Petriti, Pete A. Williams, Gerassimos Lascaratos, Kai-Yin Chau, David F. Garway-Heath

Get full text

A serum protein signature at the time of Uveal Melanoma diagnosis predicts long-term patient survival by Christina Herrspiegel, Flavia Plastino, Emma Lardner, Stefan Seregard, Pete A. Williams, Helder André, Gustav Stålhammar

Get full text

Valproic Acid Reduces Neuroinflammation to Provide Retinal Ganglion Cell Neuroprotection in the Retina Axotomy Model by James R. Tribble, Elizabeth Kastanaki, A. Berşan Uslular, Carola Rutigliani, Tim J. Enz, Pete A. Williams

Get full text

GlyCAM1 negatively regulates monocyte entry into the optic nerve head and contributes to radiation-based protection in glaucoma by Pete A. Williams, Catherine E. Braine, Nicole E. Foxworth, Kelly E. Cochran, Simon W. M. John

Get full text

Widespread retina and optic nerve neuroinflammation in enucleated eyes from glaucoma patients by Carola Rutigliani, James R. Tribble, Anna Hagström, Emma Lardner, Gauti Jóhannesson, Gustav Stålhammar, Pete A. Williams

Get full text

Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma by James R. Tribble, Flora Hui, Melissa Jöe, Katharina Bell, Vicki Chrysostomou, Jonathan G. Crowston, Pete A. Williams

Get full text

NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve by James R. Tribble, Anna Hagström, Kenza Jusseaume, Emma Lardner, Raymond Ching-Bong Wong, Gustav Stålhammar, Pete A. Williams

Get full text

Pyrroloquinoline quinone drives ATP synthesis in vitro and in vivo and provides retinal ganglion cell neuroprotection by Alessio Canovai, James R. Tribble, Melissa Jöe, Daniela Y. Westerlund, Rosario Amato, Ian A. Trounce, Massimo Dal Monte, Pete A. Williams

Get full text

Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection by Anne Rombaut, Danica Jovancevic, Raymond Ching-Bong Wong, Alan Nicol, Rune Brautaset, David I. Finkelstein, Christine T. O. Nguyen, James R. Tribble, Pete A. Williams

Get full text

Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection by Myungjin Kim, Jun Yong Kim, Won-Kyu Rhim, Gloria Cimaglia, Andrew Want, James E. Morgan, Pete A. Williams, Chun Gwon Park, Dong Keun Han, Seungsoo Rho

Get full text

Evaluating the effect of rapamycin treatment in Alzheimer’s disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol by Jonas E. Svensson, Martin Bolin, Daniel Thor, Pete A. Williams, Rune Brautaset, Marcus Carlsson, Peder Sörensson, David Marlevi, Rubens Spin-Neto, Monika Probst, Göran Hagman, Anton Forsberg Morén, Miia Kivipelto, Pontus Plavén-Sigray

Get full text

Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production by James R. Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E. Wheelock, Gauti Jóhannesson, Raymond C. B. Wong, Michael P. Coleman, Andrea Brancale, Pete A. Williams

Get full text